Institutional Manager · CIK 0001395064
TAKEDA PHARMACEUTICAL CO LTD
Tokyo, M0 · File #028-24938
Latest AUM
$16.4M
Positions
9
Top-10 Concentration
100.0%
Filings
8
Portfolio Value Over Time
2024-12
2024-12
2024-12
2024-12
2024-12
2025-03
2025-06
2025-09
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| EXITED | HilleVax, Inc. | 43157M102 | -6,724,000 | -$13.4M | $0 |
| EXITED | Turnstone Biologics | 90042W100 | -895,824 | -$321,601 | $0 |
| ADD | Lyell Immunopharma, Inc. | 55083R104 | +13,722 | +$222,845 | +$304,614 |
| EXITED | Third Harmonic Bio, Inc. | 88427A107 | -36,835 | -$200,014 | $0 |
| REDUCE | Equillium, Inc. | 29446K106 | 0 | $0 | +$2.0M |
| REDUCE | Ovid Therapeutics, Inc. | 690469101 | 0 | $0 | +$1.7M |
| REDUCE | Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | 98422T100 | 0 | $0 | +$240,149 |
| REDUCE | Shattuck Labs, Inc. | 82024L103 | 0 | $0 | +$824,062 |
| REDUCE | Rani Therapeutics Holdings, Inc. | 753018100 | 0 | $0 | -$2,865 |
| REDUCE | Standard Biotools, Inc. | 34385P108 | 0 | $0 | +$1,652 |
Filing History
- 13F HOLDINGS REPORTQ/E Sep 20259 pos · $16.4M
- 13F HOLDINGS REPORTQ/E Jun 202512 pos · $19.6M
- 13F HOLDINGS REPORTQ/E Mar 202512 pos · $16.2M
- 13F HOLDINGS REPORTQ/E Dec 202416 pos · $327.5M
- 13F HOLDINGS REPORTQ/E Dec 202415 pos · $232.3M
- 13F HOLDINGS REPORTQ/E Dec 202412 pos · $38.0M
- 13F HOLDINGS REPORTQ/E Dec 202417 pos · $289.0M
- 13F HOLDINGS REPORTQ/E Dec 202412 pos · $26.6M
Top 9 Holdings — Sep 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | Ovid Therapeutics, Inc. | 690469101 | 5,750,000 | $7.5M | 45.67% |
| 2 | Equillium, Inc. | 29446K106 | 1,824,977 | $2.6M | 15.94% |
| 3 | Ovid Therapeutics, Inc. | 690469101 | 1,781,996 | $2.3M | 14.15% |
| 4 | Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | 98422T100 | 1,475,121 | $1.2M | 7.59% |
| 5 | Shattuck Labs, Inc. | 82024L103 | 515,619 | $1.2M | 7.53% |
| 6 | Lyell Immunopharma, Inc. | 55083R104 | 54,887 | $891,365 | 5.45% |
| 7 | American Well Corporation | 03044L204 | 77,733 | $478,061 | 2.92% |
| 8 | Rani Therapeutics Holdings, Inc. | 753018100 | 203,190 | $101,554 | 0.62% |
| 9 | Standard Biotools, Inc. | 34385P108 | 16,515 | $21,470 | 0.13% |